SCHEMBL6207154

SCHEMBL6207154

CN(C)CCCON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126829-B1 SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS RECEPTOS LLC (US) 2026-02-18 EP disclosed
US-20250332112-A1 IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES GENEVANT SCIENCES GMBH (CH) 2025-10-30 US disclosed
US-12364686-B2 Sphingosine 1 phosphate receptor modulators RECEPTOS LLC (US) 2025-07-22 US disclosed
EP-4574172-A2 IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES GENEVANT SCIENCES GMBH (CH) 2025-06-25 EP disclosed
EP-4466250-B1 IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES GENEVANT SCIENCES GMBH (CH) 2025-03-26 EP disclosed
EP-4466250-A1 IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES GENEVANT SCIENCES GMBH (CH) 2024-11-27 EP disclosed
CN-118922401-A Ionizable cationic lipids for lipid nanoparticles 盖纳万科学有限公司 2024-11-08 CN disclosed
WO-2023144798-A1 IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES GENEVANT SCIENCES GMBH (CH) 2023-08-03 WO disclosed
US-20230203018-A1 COVALENT INHIBITORS OF KRAS ARAXES PHARMA LLC (US) 2023-06-29 US disclosed
US-20230149367-A1 SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS RECEPTOS LLC 2023-05-18 US disclosed
WO-2007025284-A1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X PHARMACEUTICALS, INC. (US) 2007-03-01 WO disclosed
WO-2007025089-A2 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X PHARMACEUTICAL, INC. (US) 2007-03-01 WO disclosed
EP-1507758-B1 INDOLE DERIVATIVES AND THEIR USE AS LIGANDS FOR CB2 RECEPTORS SANOFI AVENTIS (FR) 2005-11-02 EP disclosed
EP-1507758-A2 INDOLE DERIVATIVES AND THEIR USE AS LIGANDS FOR CB2 RECEPTORS Sanofi-Aventis (FR) 2005-02-23 EP disclosed
WO-2003097597-A2 INDOLE DERIVATIVES AND THE USE THEREOF AS CB2 RECEPTOR LIGANDS SANOFI-AVENTIS (FR) 2003-11-27 WO disclosed
US-5523303-A ANTIULCER AND -SECRETORY AGENTS; GASTRIC H+K+ ATPASE INHIBITORS; NONTOXIC; OXIMES DERIVATIVES EGIS GYOGYSZERGYAR RT. (HU) 1996-06-04 US disclosed
EP-0619298-A2 (Phenylmethylene)-2-(alkyl)-1- omega-(amino)-alkoxyimino -cycloalkane derivatives, a process for preparing them as well as medicaments containing them and the use of them EGIS GYOGYSZERGYAR RT. (HU) 1994-10-12 EP disclosed
CN-1022103-C Process for preparing substituted styrene derivatives, their pharmaceutically acceptable acid addition salts and their quaternary ammonium salts EGYT GYOGYSZERVEGYESZETI GYAR (HU) 1993-09-15 CN disclosed
CN-1034709-A The styrene derivatives that replaces EGYT GYOGYSZERVEGYESZETI GYAR (HU) 1989-08-16 CN disclosed
US-4593027-A 3-aryl-7-chloro-3,4-dihydroacridine-1,9(2H,10H)-dione 1-oximes and 1-hydrazone derivatives, their salts, a process for their preparation, agents containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1986-06-03 US disclosed